Mol Psychiatry 28:284297 Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, Brody L, Anastasovska J, Ghourab S, Hankir M, Zhang S, Carling D, Swann JR, Gibson G, Viardot A, Morrison D, Louise Thomas E, Bell JD (2014) The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism
Chemotherapy and other cancer treatments come with significant negative side effects, including heart failure, inflammation and gastrointestinal (GI) issues
When activated in the context of ER stress these factors can lead to cell apoptosis in T2DM thus contributing to the disease pathogenesis (Hu et al., 2018)
The auditory P300 event-related potential: an objective marker of the encephalopathy of chronic liver disease
The GLP-1 RA monitoring report describes more detailed information about the overall population of patients being prescribed these medications (including demographics, comorbidities, social drivers of health data like income and education, and more), and the proportion and characteristics of patients who filled a GLP-1 RA prescription over time using dispenses
The qualifying diagnoses (HFpEF, uncontrolled hypertension, CKD, pre-diabetes, prior MI, prior stroke, PAD) are the conditions where GLP-1 trials have shown direct benefit or strong biological plausibility for benefit
